INSM
INSMED Inc
NASDAQ · Healthcare · Biotechnology · US
$120.00
−3.21%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 146.70x
- P/E 2028E
- 34.72x
- P/S forward
- 11.25x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 34.60x
- Price / sales
- 23.04x
- Price / cash flow
- -33.64x
Enterprise value
- Enterprise value
- $25.6B
- EV / sales
- 22.53x
- EV / EBITDA
- -33.28x
- EV / EBIT
- -31.34x
- Market cap
- $26.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026